Log in to save to my catalogue

Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles

Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c971cb339bd0453ca49a321d5bcad548

Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles

About this item

Full title

Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-01, Vol.12 (1), p.440-20, Article 440

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The main challenges for programmed cell death 1(PD-1)/PD-1 ligand (PD-L1) checkpoint blockade lie in a lack of sufficient T cell infiltration, tumor immunosuppressive microenvironment, and the inadequate tumor accumulation and penetration of anti-PD-1/PD-L1 antibody. Resetting tumor-associated macrophages (TAMs) is a promising strategy to enhance T...

Alternative Titles

Full title

Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c971cb339bd0453ca49a321d5bcad548

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c971cb339bd0453ca49a321d5bcad548

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-020-20723-x

How to access this item